Regulation of noradrenergic system in amygdala is related to the anxiolytic-like effect of CRF1 receptor antagonist in rats

被引：0
|
作者：
Kagamiishi, Y. [1 ]
Kishi, A. [1 ]
Mikura, S. [1 ]
Tomimoto, S. [1 ]
Ohta, M. [1 ]
Satoh, S. [1 ]
Kida, J. [1 ]
Kamanaka, Y. [1 ]
机构：
[1] ONO Pharmaceutial Co Ltd, Pharmacol Res Labs, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] A Centrally Acting, Anxiolytic Angiotensin II AT1 Receptor Antagonist Prevents the Isolation Stress-Induced Decrease in Cortical CRF1 Receptor and Benzodiazepine Binding
    Juan M Saavedra
    Ines Armando
    Claudia Bregonzio
    Augusto Juorio
    Miroslava Macova
    Jaroslav Pavel
    Enrique Sanchez-Lemus
    Neuropsychopharmacology, 2006, 31 : 1123 - 1134
  • [42] The CRF1 receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats
    Kosoyan, HP
    Grigoriadis, DE
    Taché, Y
    BRAIN RESEARCH, 2005, 1056 (01) : 85 - 96
  • [43] A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding
    Saavedra, Juan M.
    Armando, Ines
    Bregonzio, Claudia
    Juorio, Augusto
    Macova, Miroslava
    Pavel, Jaroslav
    Sanchez-Lemus, Enrique
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (06) : 1123 - 1134
  • [44] Anxiolytic-like effects of NMDA-receptor antagonist injected into the ventral but not dorsal hippocampus in rats submitted to the elevated plus maze
    Hackl, L. P. N.
    Carobrez, A. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S255 - S256
  • [45] The putative AMPA receptor antagonist, LY326325, produces anxiolytic-like effects without altering locomotor activity in rats
    Kotlinska, J
    Liljequist, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (01) : 119 - 124
  • [46] The benzodiazepine-receptor antagonist flumazenil, but not the CRF1 antagonist CP-154,526 blocks the stress induced-anxiety after amygdala injection
    Navarro, M
    Knapp, DJ
    Angel, RA
    Overstreet, DH
    Breese, GR
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 58A - 58A
  • [47] The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats
    Shimazaki, Toshiharu
    Iijima, Michihiko
    Chaki, Shigeyuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 543 (1-3) : 63 - 67
  • [48] Effects of Xiaoyaosan on Stress-Induced Anxiety-Like Behavior in Rats: Involvement of CRF1 Receptor
    Jiang, You-Ming
    Li, Xiao-Juan
    Meng, Zhen-Zhi
    Liu, Yue-Yun
    Zhao, Hong-Bo
    Li, Na
    Yan, Zhi-Yi
    Ma, Qing-Yu
    Zhang, Han-Ting
    Chen, Jia-Xu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [49] Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats
    Lelas, S
    Wong, H
    Li, YW
    Heman, KL
    Ward, KA
    Zeller, KL
    Sieracki, KK
    Polino, JL
    Godonis, HE
    Ren, SX
    Yan, XX
    Arneric, SP
    Robertson, DW
    Hartig, PR
    Grossman, S
    Trainor, GL
    Taub, RA
    Zaczek, R
    Gilligan, PJ
    McElroy, JF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01): : 293 - 302
  • [50] The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats
    Lodge, DJ
    Lawrence, AJ
    REGULATORY PEPTIDES, 2003, 116 (1-3) : 27 - 33
12345